Transaction #23513 · Form 4 · 0001213900-25-123620
InMed Pharmaceuticals Inc. · Stock award · Employee Stock Option (Right to Buy)
InMed Pharmaceuticals Inc. · Transacted December 19, 2025 · Filed December 19, 2025
What does this filing report?
An SEC Form 4 filing for InMed Pharmaceuticals Inc. records a stock award involving Employee Stock Option (Right to Buy) on December 19, 2025. The reported quantity was 1,750. The filing date is December 19, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- InMed Pharmaceuticals Inc.
- Company CIK
- 0001728328
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 1,750
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 2,711
- Ownership description
- Not reported
- SEC acceptance time
- Dec 19, 2025, 11:38 AM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- HULL ANDREW ↗
Director
CIK 0001818252
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common shares
- Underlying quantity
- 1,750
- Conversion / exercise price
- 1.29
- Exercise date
- Not reported
- Expiration date
- December 18, 2030
Filing footnotes & remarks
- F1
- The options were granted on 12/19/2025 and will vest 100% on the one-year anniversary of the grant date (December 18, 2026) or immediately prior to the next Annual General Meeting, whichever is sooner.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.